Ardelyx (ARDX) Financials

$3.99 -0.19 (-4.55%)

Closing price 04:00 PM Eastern

Extended Trading

$4.00 +0.00 (+0.13%)

As of 07:36 PM Eastern

Annual Income Statements for Ardelyx

This table shows Ardelyx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	-39	-66	-67	-158	-94	-95	-91	-64	-112	18	-3.21
Consolidated Net Income / (Loss)	-39	-66	-67	-158	-94	-95	-91	-64	-112	-30	-3.21
Net Income / (Loss) Continuing Operations	-39	-66	-67	-158	-94	-95	-91	-64	-112	18	-3.21
Total Pre-Tax Income	-39	-66	-67	-158	-94	-95	-91	-63	-112	-30	-3.15
Total Operating Income	-28	-63	-64	-154	-91	-91	-91	-65	-113	-29	-1.56
Total Gross Profit	283	107	48	9.10	7.43	4.68	2.14	34	0.00	24	32
Total Revenue	334	124	52	10	7.57	5.28	2.61	42	0.00	24	32
Operating Revenue	334	124	52	10	7.57	5.28	2.61	42	0.00	24	32
Total Cost of Revenue	51	18	4.12	1.00	0.15	0.60	0.47	8.40	0.00	0.00	0.00
Operating Cost of Revenue	51	18	4.12	1.00	0.15	0.60	0.47	8.40	0.00	0.00	-
Total Operating Expenses	311	170	112	163	98	96	93	99	113	5.36	33
Selling, General & Admin Expense	259	134	77	72	33	24	24	23	19	14	7.29
Research & Development Expense	52	36	35	91	65	72	69	75	94	40	26
Total Other Income / (Expense), net	-11	-2.24	-3.44	-3.82	-3.53	-3.37	-0.35	1.96	0.51	-0.26	-1.58
Interest Expense	20	8.87	5.07	4.50	5.10	5.73	3.53	-	0.00	-	-
Other Income / (Expense), net	9.17	6.63	1.63	0.69	1.57	2.35	3.19	1.96	0.51	-0.26	-1.58
Income Tax Expense	0.27	0.55	0.01	0.00	0.00	0.30	0.00	1.18	0.00	-0.03	0.07
Basic Earnings per Share	($0.17)	($0.30)	($0.42)	($1.52)	($1.05)	($1.47)	($1.62)	($1.36)	($2.80)	($1.29)	($0.31)
Weighted Average Basic Shares Outstanding	235.23M	219.33M	158.69M	104.21M	89.58M	64.48M	56.22M	47.44M	40.12M	22.89M	10.25M
Diluted Earnings per Share	($0.17)	($0.30)	($0.42)	($1.52)	($1.05)	($1.47)	($1.62)	($1.36)	($2.80)	($1.29)	($0.31)
Weighted Average Diluted Shares Outstanding	235.23M	219.33M	158.69M	104.21M	89.58M	64.48M	56.22M	47.44M	40.12M	22.89M	10.25M
Weighted Average Basic & Diluted Shares Outstanding	238.36M	232.69M	206.49M	130.29M	89.58M	64.48M	56.22M	47.44M	40.12M	22.89M	10.25M

This table shows Ardelyx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-41	4.65	-0.81	-16	-27	-29	6.63	-17	-27	11	-23
Consolidated Net Income / (Loss)	-41	4.65	-0.81	-16	-27	-29	6.63	-17	-27	11	-23
Net Income / (Loss) Continuing Operations	-41	4.65	-0.81	-16	-27	-29	6.63	-17	-27	11	-23
Total Pre-Tax Income	-40	4.68	-0.77	-16	-26	-28	6.83	-17	-27	11	-23
Total Operating Income	-36	8.13	2.23	-14	-25	-28	7.40	-17	-26	12	-22
Total Gross Profit	62	98	83	64	39	29	49	19	9.83	41	4.25
Total Revenue	74	116	98	73	46	34	56	22	11	44	4.99
Operating Revenue	74	116	98	73	46	34	56	22	11	44	4.99
Total Cost of Revenue	12	18	16	9.44	7.13	5.08	7.69	3.49	1.54	3.16	0.73
Operating Cost of Revenue	12	18	16	9.44	7.13	5.08	7.69	3.49	1.54	3.16	0.73
Total Operating Expenses	98	90	80	77	64	57	41	35	36	29	26
Selling, General & Admin Expense	83	76	65	65	53	48	33	27	27	20	19
Research & Development Expense	15	14	15	13	11	9.52	8.64	8.28	9.09	9.14	7.47
Total Other Income / (Expense), net	-3.94	-3.45	-3.00	-2.76	-1.72	-0.48	-0.57	-0.50	-0.70	-1.46	-1.01
Interest Expense	6.26	5.85	5.28	4.90	4.06	2.81	2.03	2.04	2.00	1.83	1.72
Other Income / (Expense), net	2.33	2.41	2.28	2.15	2.34	2.32	1.46	1.55	1.30	0.38	0.70
Income Tax Expense	0.86	0.04	0.04	0.07	0.12	0.33	0.20	0.00	0.01	-	0.00
Basic Earnings per Share	($0.17)	$0.01	$0.00	($0.07)	($0.11)	($0.12)	$0.03	($0.08)	($0.13)	$0.12	($0.14)
Weighted Average Basic Shares Outstanding	238.62M	235.23M	235.91M	234.57M	233.07M	219.33M	222.78M	214.95M	207.02M	158.69M	165.10M
Diluted Earnings per Share	($0.17)	$0.01	$0.00	($0.07)	($0.11)	($0.12)	$0.03	($0.08)	($0.13)	$0.12	($0.14)
Weighted Average Diluted Shares Outstanding	238.62M	235.23M	235.91M	234.57M	233.07M	219.33M	227.89M	214.95M	207.02M	158.69M	165.10M
Weighted Average Basic & Diluted Shares Outstanding	239.26M	238.36M	236.85M	235.43M	233.98M	232.69M	232.14M	217.86M	214.46M	206.49M	187.46M

This table details how cash moves in and out of Ardelyx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	43	-75	24	-19	-90	102	3.39	0.79	-32	-0.28	73
Net Cash From Operating Activities	-45	-90	-70	-153	-81	-76	-70	-65	-93	-72	13
Net Cash From Continuing Operating Activities	-45	-90	-70	-153	-81	-76	-70	-65	-93	-72	13
Net Income / (Loss) Continuing Operations	-39	-66	-67	-158	-94	-95	-91	-64	-112	-30	-3.21
Consolidated Net Income / (Loss)	-39	-66	-67	-158	-94	-95	-91	-64	-112	-30	-3.21
Depreciation Expense	2.06	1.29	1.14	2.81	2.54	2.50	2.68	2.64	1.30	0.83	0.30
Amortization Expense	7.40	4.22	1.96	0.28	0.41	0.76	-0.65	0.58	0.45	0.46	0.00
Non-Cash Adjustments To Reconcile Net Income	45	7.56	8.79	5.04	13	16	9.53	9.59	5.32	2.70	3.29
Changes in Operating Assets and Liabilities, net	-61	-37	-15	-2.52	-3.56	-0.83	9.46	-14	13	-46	13
Net Cash From Investing Activities	-18	-131	18	51	-31	23	-30	65	-131	-3.45	-1.86
Net Cash From Continuing Investing Activities	-18	-131	18	51	-31	23	-30	65	-131	-3.45	-1.86
Purchase of Property, Plant & Equipment	-1.01	-0.34	-0.06	-1.87	-0.32	-0.33	-0.31	-2.36	-4.87	-3.45	-1.86
Purchase of Investments	-195	-215	-50	-73	-151	-103	-169	-84	-134	0.00	0.00
Sale of Property, Plant & Equipment	0.00	0.00	1.80	0.00	0.00	-	-	-	-	-	-
Sale and/or Maturity of Investments	178	84	67	126	120	126	139	152	7.60	0.00	0.00
Net Cash From Financing Activities	107	146	75	83	23	155	104	0.69	191	75	61
Net Cash From Continuing Financing Activities	107	146	75	83	23	155	104	0.69	191	75	61
Repayment of Debt	0.00	0.00	-33	-19	-0.13	0.00	0.00	-	-	-	-0.00
Issuance of Debt	99	22	27	0.00	0.00	-	49	-	0.00	0.03	-
Issuance of Common Equity	8.14	120	72	103	23	21	0.49	0.62	191	75	61
Other Financing Activities, net	-1.00	3.50	9.58	-0.11	0.00	135	54	0.06	-	-	-
Cash Interest Paid	11	4.24	2.90	3.47	4.20	4.92	3.07	-	-	-	-
Cash Income Taxes Paid	0.27	0.05	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.00

This table details how cash moves in and out of Ardelyx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-34	18	5.54	5.74	15	-12	3.71	-62	-3.65	35	8.22
Net Cash From Operating Activities	-38	9.81	0.50	-19	-36	-8.72	-21	-15	-45	14	-25
Net Cash From Continuing Operating Activities	-38	9.81	0.50	-19	-36	-8.72	-21	-15	-45	14	-25
Net Income / (Loss) Continuing Operations	-41	4.65	-0.81	-16	-27	-29	6.63	-17	-27	11	-23
Consolidated Net Income / (Loss)	-41	4.65	-0.81	-16	-27	-29	6.63	-17	-27	11	-23
Depreciation Expense	0.60	0.52	0.54	0.57	0.44	0.36	0.29	0.64	-0.00	0.13	0.28
Amortization Expense	2.14	1.98	2.01	1.66	1.75	1.13	-0.82	2.87	1.04	0.91	0.90
Non-Cash Adjustments To Reconcile Net Income	11	17	0.98	7.03	21	-4.73	6.18	2.07	4.05	9.03	4.00
Changes in Operating Assets and Liabilities, net	-11	-14	-2.22	-12	-32	23	-33	-3.59	-23	-6.47	-7.72
Net Cash From Investing Activities	2.85	-42	2.34	24	-2.57	-30	-33	-59	-9.78	1.44	-0.83
Net Cash From Continuing Investing Activities	2.85	-42	2.34	24	-2.57	-30	-33	-59	-9.78	1.44	-0.83
Purchase of Property, Plant & Equipment	-0.33	-0.59	-0.14	-0.13	-0.15	-0.04	-0.19	-0.09	-0.01	-0.06	-
Purchase of Investments	-32	-99	-40	-23	-34	-78	-50	-67	-21	-6.50	-18
Sale and/or Maturity of Investments	35	58	42	47	32	48	17	8.25	11	8.00	17
Net Cash From Financing Activities	1.48	49	2.70	1.61	53	26	58	12	51	19	34
Net Cash From Continuing Financing Activities	1.48	49	2.70	1.61	53	26	58	12	51	19	34
Issuance of Debt	0.00	50	-	-	50	22	-	-	0.00	-	-
Issuance of Common Equity	1.48	0.61	2.70	1.61	3.22	0.10	58	12	51	19	34
Cash Interest Paid	2.45	4.45	2.93	1.94	2.10	1.55	0.94	0.90	0.86	0.82	0.72
Cash Income Taxes Paid	0.00	-0.01	-	0.27	0.00	0.03	-	0.02	0.00	-	-

This table presents Ardelyx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	436	298	190	150	202	260	183	158	213	117	113
Total Current Assets	356	246	154	134	195	252	176	150	204	112	111
Cash & Equivalents	65	21	96	72	91	181	79	75	75	107	107
Short-Term Investments	185	163	28	44	95	66	89	59	126	0.00	-
Accounts Receivable	58	22	7.73	0.50	0.00	-	0.09	11	0.00	-	2.58
Inventories, net	21	12	3.28	0.00	-	-	-	-	-	-	-
Prepaid Expenses	27	27	19	16	8.20	3.80	3.20	4.94	3.17	5.03	1.21
Plant, Property, & Equipment, net	1.50	1.01	1.22	2.36	1.94	3.44	5.61	8.03	8.99	4.71	2.13
Total Noncurrent Assets	78	50	35	14	4.94	4.28	1.35	0.16	0.15	0.20	0.20
Other Noncurrent Operating Assets	78	50	35	14	2.83	4.28	1.35	0.16	0.15	0.10	0.10
Total Liabilities & Shareholders' Equity	436	298	190	150	202	260	183	158	213	117	113
Total Liabilities	262	131	92	67	75	73	68	19	20	8.05	53
Total Current Liabilities	78	50	66	53	28	22	18	18	19	7.72	22
Accounts Payable	16	11	11	4.28	5.63	2.19	1.15	3.93	5.64	2.78	3.13
Accrued Expenses	35	15	12	7.37	6.66	7.25	13	11	10	2.58	0.78
Current Deferred Revenue	11	7.18	4.21	0.00	4.18	4.54	-	-	-	-	16
Current Employee Benefit Liabilities	15	13	7.55	5.42	5.67	4.45	2.72	3.23	3.16	2.37	1.65
Other Current Liabilities	1.56	4.44	3.89	3.49	2.12	2.61	1.00	0.00	-	-	-
Total Noncurrent Liabilities	185	80	26	14	47	51	50	0.72	0.78	0.32	31
Long-Term Debt	151	50	0.00	-	47	49	50	0.00	-	-	-
Noncurrent Deferred Revenue	7.23	8.64	9.03	4.73	0.00	-	-	-	-	-	31
Other Noncurrent Operating Liabilities	27	22	17	9.75	0.41	2.08	-	0.72	0.78	0.32	0.12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	173	167	98	83	126	187	116	139	193	109	61
Total Preferred & Common Equity	173	167	98	83	126	187	116	139	193	109	61
Total Common Equity	173	167	98	83	126	187	116	139	193	109	61
Common Stock	1,059	1,013	879	796	681	647	481	418	407	210	133
Retained Earnings	-885	-846	-780	-713	-555	-460	-366	-278	-214	-101	-72
Accumulated Other Comprehensive Income / (Loss)	0.06	0.22	-0.05	-0.01	-0.00	0.02	-0.04	-0.05	-0.07	0.00	-

This table presents Ardelyx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	410	368	343	342	289	211	217	145
Total Current Assets	313	284	263	258	241	162	167	120
Cash & Equivalents	31	47	42	36	34	30	92	62
Short-Term Investments	183	143	144	166	131	98	38	29
Accounts Receivable	46	53	37	28	43	9.11	12	5.21
Inventories, net	24	11	14	9.81	8.52	7.62	4.82	1.25
Prepaid Expenses	28	29	26	17	24	18	20	23
Plant, Property, & Equipment, net	1.67	1.03	1.02	1.02	1.12	1.06	1.10	1.29
Total Noncurrent Assets	96	83	79	83	47	48	49	24
Other Noncurrent Operating Assets	96	83	79	83	47	48	49	24
Total Liabilities & Shareholders' Equity	410	368	343	342	289	211	217	145
Total Liabilities	265	210	196	191	98	88	92	78
Total Current Liabilities	76	70	62	57	44	62	63	52
Accounts Payable	14	16	11	17	7.74	5.29	11	3.11
Accrued Expenses	43	33	27	22	19	12	11	7.34
Current Deferred Revenue	11	7.27	11	6.59	4.07	5.96	5.55	4.00
Current Employee Benefit Liabilities	7.17	12	10	6.73	8.36	6.88	5.07	7.17
Other Current Liabilities	1.30	2.57	3.55	4.31	4.32	4.11	4.00	3.79
Total Noncurrent Liabilities	189	139	134	135	55	26	29	26
Long-Term Debt	151	101	100	100	27	-	-	-
Noncurrent Deferred Revenue	8.35	13	9.61	12	10	9.24	11	8.56
Other Noncurrent Operating Liabilities	29	26	24	23	17	17	17	17
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	146	158	147	151	191	123	125	67
Total Preferred & Common Equity	146	158	147	151	191	123	125	67
Total Common Equity	146	158	147	151	191	123	125	67
Common Stock	1,072	1,048	1,036	1,024	1,009	947	932	858
Retained Earnings	-926	-890	-889	-873	-817	-824	-807	-791
Accumulated Other Comprehensive Income / (Loss)	0.02	0.19	-0.10	-0.02	-0.20	-0.21	-0.02	-0.11

This table displays calculated financial ratios and metrics derived from Ardelyx's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	168.06%	138.61%	416.57%	33.36%	43.36%	102.57%	-93.79%	0.00%	-100.00%	-24.02%	9.32%
EBITDA Growth	81.79%	13.36%	60.80%	-74.56%	-0.71%	0.09%	-43.02%	45.82%	-290.08%	-896.94%	51.21%
EBIT Growth	66.85%	8.82%	59.57%	-72.24%	-0.34%	-1.31%	-38.95%	43.80%	-279.05%	-842.17%	51.00%
NOPAT Growth	55.83%	0.76%	58.69%	-70.02%	0.53%	-0.35%	-39.67%	42.32%	-284.14%	-1,779.09%	45.41%
Net Income Growth	40.76%	1.70%	57.51%	-67.70%	0.66%	-3.99%	-41.90%	42.75%	-279.42%	-821.62%	51.04%
EPS Growth	43.33%	28.57%	72.37%	-44.76%	28.57%	9.26%	-19.12%	51.43%	-117.05%	-316.13%	94.67%
Operating Cash Flow Growth	50.06%	-28.09%	54.08%	-87.33%	-6.47%	-8.84%	-7.80%	29.55%	-28.81%	-636.24%	639.76%
Free Cash Flow Firm Growth	18.85%	-58.72%	59.66%	-88.12%	-12.90%	0.57%	4.69%	15.77%	-0.70%	-782.12%	-69.75%
Invested Capital Growth	128.96%	2,759.33%	162.56%	84.54%	-7.89%	-336.34%	-146.57%	169.55%	-526.93%	103.85%	-31.62%
Revenue Q/Q Growth	32.47%	-7.31%	478.95%	-7.17%	-5.29%	70.14%	-94.15%	0.00%	0.00%	-20.87%	0.00%
EBITDA Q/Q Growth	79.98%	-281.40%	44.97%	-5.52%	-12.48%	9.29%	-79.61%	41.68%	-15.10%	-79.22%	0.00%
EBIT Q/Q Growth	65.85%	-206.79%	43.47%	-5.27%	-11.45%	8.29%	-75.38%	40.26%	-14.55%	-79.11%	0.00%
NOPAT Q/Q Growth	56.37%	-173.37%	42.65%	-5.20%	-10.73%	8.55%	-72.87%	39.46%	-14.85%	-78.71%	0.00%
Net Income Q/Q Growth	46.08%	-148.65%	41.12%	-4.88%	-10.66%	7.84%	-71.22%	39.15%	-14.55%	-78.54%	0.00%
EPS Q/Q Growth	43.33%	-400.00%	50.59%	0.65%	-5.00%	10.91%	-68.75%	37.90%	6.67%	-187.16%	0.00%
Operating Cash Flow Q/Q Growth	29.25%	-34.48%	43.42%	-16.74%	-8.61%	8.71%	-49.08%	32.54%	-5.89%	-32.97%	-52.32%
Free Cash Flow Firm Q/Q Growth	-1.88%	-13.14%	46.76%	-24.58%	-2.33%	9.29%	-28.26%	26.61%	-5.98%	0.00%	0.00%
Invested Capital Q/Q Growth	7.93%	-39.34%	-59.30%	79.32%	-1,556.94%	-136.64%	-161.18%	301.28%	-6.66%	144.73%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	84.85%	85.70%	92.11%	90.10%	98.08%	88.64%	82.13%	80.00%	0.00%	100.00%	100.00%
EBITDA Margin	-2.79%	-41.09%	-113.16%	-1,491.23%	-1,139.32%	-1,621.87%	-3,288.42%	-142.72%	0.00%	-118.05%	-9.00%
Operating Margin	-8.38%	-50.84%	-122.24%	-1,528.63%	-1,199.05%	-1,728.14%	-3,488.57%	-155.04%	0.00%	-122.32%	-4.95%
EBIT Margin	-5.63%	-45.51%	-119.11%	-1,521.83%	-1,178.34%	-1,683.60%	-3,366.32%	-150.38%	0.00%	-123.41%	-9.95%
Profit (Net Income) Margin	-11.73%	-53.08%	-128.85%	-1,566.46%	-1,245.71%	-1,797.77%	-3,502.03%	-153.19%	0.00%	-123.29%	-10.16%
Tax Burden Percent	100.68%	100.83%	100.01%	100.00%	100.00%	100.32%	100.00%	101.87%	100.00%	99.90%	102.13%
Interest Burden Percent	207.02%	115.67%	108.17%	102.93%	105.72%	106.44%	104.03%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-36.78%	-264.67%	0.00%	0.00%	0.00%	0.00%	-4,466.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-20.04%	-245.88%	0.00%	0.00%	0.00%	0.00%	-4,444.10%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	13.77%	214.84%	0.00%	0.00%	0.00%	0.00%	4,394.43%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-23.01%	-49.83%	-74.28%	-151.55%	-60.31%	-62.78%	-71.57%	-38.70%	-74.42%	-34.93%	-12.05%
Cash Return on Invested Capital (CROIC)	-115.19%	-451.16%	-4,206.04%	0.00%	0.00%	0.00%	0.00%	-1,097.99%	0.00%	-3,843.81%	0.00%
Operating Return on Assets (OROA)	-5.12%	-23.23%	-36.55%	-87.44%	-38.67%	-40.13%	-51.44%	-34.05%	0.00%	-25.74%	-4.03%
Return on Assets (ROA)	-10.67%	-27.10%	-39.54%	-90.00%	-40.89%	-42.85%	-53.51%	-34.68%	0.00%	-25.72%	-4.11%
Return on Common Equity (ROCE)	-23.01%	-49.83%	-74.28%	-151.55%	-60.31%	-62.78%	-71.57%	-38.70%	-74.42%	-34.93%	0.63%
Return on Equity Simple (ROE_SIMPLE)	-22.58%	-39.60%	-68.35%	-191.44%	-74.79%	-50.86%	-78.83%	-46.18%	-58.19%	-27.20%	-5.30%
Net Operating Profit after Tax (NOPAT)	-20	-44	-45	-108	-64	-64	-64	-46	-79	-21	-1.09
NOPAT Margin	-5.86%	-35.59%	-85.57%	-1,070.04%	-839.33%	-1,209.70%	-2,442.00%	-108.53%	0.00%	-85.63%	-3.46%
Net Nonoperating Expense Percent (NNEP)	-16.75%	-18.80%	-24.86%	-45.11%	-18.35%	-19.67%	-21.91%	-11.21%	-21.67%	-8.44%	-3.13%
Return On Investment Capital (ROIC_SIMPLE)	-6.04%	-20.45%	-35.69%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	15.15%	14.30%	7.89%	9.90%	1.92%	11.36%	17.88%	20.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	77.54%	107.99%	146.86%	716.08%	437.89%	459.52%	909.67%	55.31%	0.00%	56.31%	23.04%
R&D to Revenue	15.68%	28.55%	67.49%	902.64%	859.24%	1,357.26%	2,661.03%	179.72%	0.00%	166.01%	81.90%
Operating Expenses to Revenue	93.22%	136.54%	214.35%	1,618.73%	1,297.13%	1,816.78%	3,570.69%	235.04%	0.00%	22.32%	104.95%
Earnings before Interest and Taxes (EBIT)	-19	-57	-62	-154	-89	-89	-88	-63	-112	-30	-3.15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-9.31	-51	-59	-151	-86	-86	-86	-60	-111	-28	-2.85
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.93	8.63	5.43	1.50	4.63	2.53	0.96	2.25	3.48	4.32	5.77
Price to Tangible Book Value (P/TBV)	6.93	8.63	5.43	1.50	4.63	2.53	0.96	2.25	3.48	4.32	5.77
Price to Revenue (P/Rev)	3.60	11.56	10.24	12.28	77.12	89.40	42.66	7.47	0.00	19.58	11.07
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.52	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.92%	0.00%
Enterprise Value to Invested Capital (EV/IC)	14.88	40.35	386.44	0.00	0.00	0.00	0.00	33.69	0.00	202.19	0.00
Enterprise Value to Revenue (EV/Rev)	3.30	10.48	8.38	3.92	58.92	52.00	0.00	4.28	0.00	15.12	7.68
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	18.13
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	23.99
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.87	0.30	0.27	0.39	0.40	0.27	0.43	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.87	0.30	0.00	0.00	0.37	0.26	0.43	0.00	0.00	0.00	0.00
Financial Leverage	-0.69	-0.87	-1.00	-1.06	-1.07	-1.04	-0.99	-1.01	-1.02	-1.26	-2.54
Leverage Ratio	2.16	1.84	1.88	1.68	1.48	1.47	1.34	1.12	1.09	1.36	2.93
Compound Leverage Factor	4.46	2.13	2.03	1.73	1.56	1.56	1.39	1.12	1.09	1.36	2.93
Debt to Total Capital	46.54%	23.00%	21.36%	28.08%	28.71%	21.13%	30.07%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	21.36%	28.08%	2.36%	0.50%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	46.54%	23.00%	0.00%	0.00%	26.35%	20.63%	30.07%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.46%	77.00%	78.64%	71.92%	71.29%	78.87%	69.93%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	-16.20	-0.97	-0.45	-0.21	-0.59	-0.58	-0.58	0.00	0.00	0.00	0.00
Net Debt to EBITDA	10.66	2.63	1.65	0.56	1.60	2.31	1.38	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	-16.20	-0.97	0.00	0.00	-0.54	-0.57	-0.58	0.00	0.00	0.00	0.00
Debt to NOPAT	-7.71	-1.12	-0.60	-0.30	-0.80	-0.78	-0.78	0.00	0.00	0.00	0.00
Net Debt to NOPAT	5.07	3.04	2.18	0.78	2.17	3.09	1.86	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	-7.71	-1.12	0.00	0.00	-0.73	-0.76	-0.78	0.00	0.00	0.00	0.00
Altman Z-Score	1.29	3.20	-2.50	-8.22	0.36	1.34	-2.33	7.61	18.07	34.30	4.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	105.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.58	4.88	2.34	2.53	6.85	11.34	9.95	8.38	10.62	14.51	5.16
Quick Ratio	3.95	4.09	2.01	2.22	6.56	11.14	9.49	8.10	10.46	13.86	5.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-61	-76	-48	-118	-63	-56	-56	-59	-70	-69	10
Operating Cash Flow to CapEx	-4,432.15%	-26,080.52%	0.00%	-8,170.92%	-25,134.26%	-23,533.54%	-22,596.14%	-2,768.15%	-1,901.64%	-2,079.91%	721.82%
Free Cash Flow to Firm to Interest Expense	-3.05	-8.51	-9.38	-26.20	-12.29	-9.70	-15.80	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-2.23	-10.11	-13.81	-33.89	-15.97	-13.36	-19.89	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-2.28	-10.15	-13.46	-34.30	-16.03	-13.41	-19.97	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.91	0.51	0.31	0.06	0.03	0.02	0.02	0.23	0.00	0.21	0.40
Accounts Receivable Turnover	8.37	8.36	12.67	0.00	0.00	0.00	0.48	0.00	0.00	0.00	7.01
Inventory Turnover	3.01	2.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	266.47	111.52	29.10	4.70	2.82	1.17	0.38	4.93	0.00	7.02	23.77
Accounts Payable Turnover	3.73	1.62	0.54	0.20	0.04	0.36	0.18	1.76	0.00	0.00	0.00
Days Sales Outstanding (DSO)	43.62	43.65	28.81	0.00	0.00	0.00	761.71	0.00	0.00	0.00	52.06
Days Inventory Outstanding (DIO)	121.37	161.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	97.96	225.59	670.95	1,807.30	9,833.60	1,014.40	1,989.88	207.88	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	67.02	-20.63	-642.14	-1,807.30	-9,833.60	-1,014.40	-1,228.16	-207.88	0.00	0.00	52.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74	32	1.13	-1.81	-12	-11	-2.49	5.34	-7.67	1.80	-47
Invested Capital Turnover	6.27	7.44	-154.09	-1.50	-0.67	-0.79	1.83	-35.96	0.00	-1.07	-0.77
Increase / (Decrease) in Invested Capital	42	31	2.94	9.89	-0.86	-8.36	-7.82	13	-9.47	49	-11
Enterprise Value (EV)	1,102	1,305	437	40	446	275	-7.08	180	471	363	243
Market Capitalization	1,201	1,439	534	124	584	472	111	314	672	470	350
Book Value per Share	$0.73	$0.72	$0.52	$0.73	$1.40	$2.97	$1.86	$2.93	$4.08	$4.20	$3.27
Tangible Book Value per Share	$0.73	$0.72	$0.52	$0.73	$1.40	$2.97	$1.86	$2.93	$4.08	$4.20	$3.27
Total Capital	324	217	125	115	177	237	166	139	193	109	61
Total Debt	151	50	27	32	51	50	50	0.00	0.00	0.00	0.00
Total Long-Term Debt	151	50	0.00	0.00	47	49	50	0.00	0.00	0.00	0.00
Net Debt	-99	-134	-97	-84	-138	-197	-118	-134	-201	-107	-107
Capital Expenditures (CapEx)	1.01	0.34	-1.74	1.87	0.32	0.33	0.31	2.36	4.87	3.45	1.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)	29	11	-9.20	-3.60	-16	-16	-9.45	-2.14	-16	-2.70	-18
Debt-free Net Working Capital (DFNWC)	279	196	115	113	170	231	159	132	185	104	90
Net Working Capital (NWC)	279	196	88	81	166	230	159	132	185	104	90
Net Nonoperating Expense (NNE)	20	22	23	50	31	31	28	19	33	9.05	2.12
Net Nonoperating Obligations (NNO)	-99	-134	-97	-84	-138	-197	-118	-134	-201	-107	-107
Total Depreciation and Amortization (D&A)	9.46	5.51	3.11	3.09	2.95	3.26	2.03	3.22	1.75	1.29	0.30
Debt-free, Cash-free Net Working Capital to Revenue	8.55%	9.18%	-17.63%	-35.62%	-211.95%	-312.19%	-362.33%	-5.08%	0.00%	-11.22%	-56.11%
Debt-free Net Working Capital to Revenue	83.52%	157.26%	219.93%	1,120.06%	2,251.18%	4,374.65%	6,085.27%	313.91%	0.00%	434.15%	283.16%
Net Working Capital to Revenue	83.52%	157.26%	168.72%	800.52%	2,196.14%	4,352.24%	6,085.27%	313.91%	0.00%	434.15%	283.16%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.17)	($0.30)	($0.42)	($1.52)	($1.05)	($1.47)	($1.62)	($1.36)	($2.80)	($1.29)	($0.31)
Adjusted Weighted Average Basic Shares Outstanding	235.23M	219.33M	158.69M	104.21M	98.68M	88.93M	62.60M	47.60M	47.33M	34.63M	18.60M
Adjusted Diluted Earnings per Share	($0.17)	($0.30)	($0.42)	($1.52)	($1.05)	($1.47)	($1.62)	($1.36)	($2.80)	($1.29)	($0.31)
Adjusted Weighted Average Diluted Shares Outstanding	235.23M	219.33M	158.69M	104.21M	98.68M	88.93M	62.60M	47.60M	47.33M	34.63M	18.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.05)	($1.47)	($1.62)	($1.36)	($2.80)	($1.29)	($0.31)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	238.36M	232.69M	206.49M	130.29M	89.58M	64.48M	56.22M	47.44M	40.12M	22.89M	10.25M
Normalized Net Operating Profit after Tax (NOPAT)	-20	-44	-45	-108	-64	-64	-64	-46	-79	-21	-1.09
Normalized NOPAT Margin	-5.86%	-35.59%	-85.57%	-1,070.04%	-839.33%	-1,209.70%	-2,442.00%	-108.53%	0.00%	-85.63%	-3.46%
Pre Tax Income Margin	-11.65%	-52.65%	-128.84%	-1,566.42%	-1,245.69%	-1,792.03%	-3,501.88%	-150.38%	0.00%	-123.41%	-9.95%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.93	-6.38	-12.25	-34.13	-17.50	-15.53	-24.83	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-0.97	-4.99	-8.80	-24.00	-12.46	-11.16	-18.01	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-0.98	-6.42	-11.90	-34.55	-17.56	-15.58	-24.92	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.02	-5.03	-8.45	-24.41	-12.53	-11.21	-18.10	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Ardelyx's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	61.04%	237.95%	74.21%	227.86%	304.81%	-22.22%	1,030.99%	784.13%	2,329.27%	4,193.29%	325.06%
EBITDA Growth	-55.25%	153.89%	-15.16%	19.98%	15.05%	-278.39%	141.67%	55.21%	11.33%	139.07%	51.83%
EBIT Growth	-52.30%	141.04%	-49.03%	23.83%	9.79%	-305.02%	141.83%	42.33%	9.37%	135.51%	50.02%
NOPAT Growth	-47.29%	141.16%	-78.23%	18.01%	5.32%	-261.33%	146.89%	36.59%	6.27%	149.18%	48.20%
Net Income Growth	-55.16%	116.13%	-112.20%	3.90%	0.95%	-369.30%	128.96%	36.44%	4.62%	129.52%	47.48%
EPS Growth	-54.55%	108.33%	-100.00%	12.50%	15.38%	-200.00%	121.43%	57.89%	38.10%	138.71%	66.67%
Operating Cash Flow Growth	-7.66%	212.53%	102.33%	-31.63%	20.25%	-161.03%	15.57%	52.89%	-62.18%	136.19%	26.49%
Free Cash Flow Firm Growth	-38.69%	33.78%	68.33%	-34.34%	-9.98%	-651.91%	-61.52%	-81.61%	-140.03%	126.62%	-24.66%
Invested Capital Growth	72.44%	128.96%	28.69%	170.73%	119.57%	2,759.33%	1,818.32%	1,517.28%	3,408.48%	162.56%	131.79%
Revenue Q/Q Growth	-36.18%	18.21%	34.17%	59.10%	33.93%	-39.06%	152.50%	96.44%	-74.27%	786.04%	97.39%
EBITDA Q/Q Growth	-340.14%	84.32%	176.34%	54.06%	16.65%	-390.18%	172.01%	51.23%	-275.04%	167.78%	22.59%
EBIT Q/Q Growth	-423.01%	133.29%	139.31%	48.59%	12.96%	-389.73%	158.75%	39.11%	-297.81%	159.11%	19.01%
NOPAT Q/Q Growth	-415.52%	415.91%	116.38%	44.77%	11.82%	-372.79%	161.71%	36.22%	-250.25%	179.28%	16.54%
Net Income Q/Q Growth	-985.77%	674.17%	95.08%	37.95%	7.93%	-534.48%	138.72%	36.05%	-350.33%	146.72%	15.02%
EPS Q/Q Growth	-1,800.00%	0.00%	100.00%	36.36%	8.33%	-500.00%	137.50%	38.46%	-208.33%	185.71%	26.32%
Operating Cash Flow Q/Q Growth	-492.02%	1,858.08%	102.58%	45.70%	-309.75%	59.39%	-45.67%	67.10%	-413.60%	156.18%	18.71%
Free Cash Flow Firm Q/Q Growth	-79.32%	-145.02%	71.51%	-10.79%	14.38%	-17.18%	-20.86%	9.31%	-529.68%	134.29%	-35.89%
Invested Capital Q/Q Growth	12.13%	7.93%	11.95%	27.27%	48.88%	-39.34%	135.53%	3.22%	1,838.82%	-59.30%	274.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	83.40%	84.27%	83.99%	87.11%	84.51%	85.23%	86.36%	84.38%	86.48%	92.84%	85.32%
EBITDA Margin	-42.21%	11.22%	7.19%	-12.64%	-43.78%	-70.35%	14.77%	-51.80%	-208.65%	30.68%	-400.98%
Operating Margin	-49.04%	7.00%	2.27%	-18.61%	-53.62%	-81.44%	13.12%	-74.44%	-229.26%	27.49%	-438.83%
EBIT Margin	-45.91%	9.07%	4.60%	-15.69%	-48.54%	-74.69%	15.71%	-67.51%	-217.80%	28.34%	-424.71%
Profit (Net Income) Margin	-55.51%	4.00%	-0.82%	-22.47%	-57.62%	-83.82%	11.76%	-76.66%	-235.49%	24.21%	-459.15%
Tax Burden Percent	102.13%	99.25%	105.61%	100.41%	100.46%	101.17%	97.07%	100.00%	100.05%	100.00%	100.00%
Interest Burden Percent	118.41%	44.43%	-16.97%	142.68%	118.17%	110.93%	77.09%	113.55%	108.06%	85.44%	108.11%
Effective Tax Rate	0.00%	0.75%	0.00%	0.00%	0.00%	0.00%	2.93%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-189.34%	43.55%	6.57%	-65.22%	-170.45%	-423.97%	60.97%	-410.50%	-897.41%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-170.35%	46.48%	8.66%	-57.80%	-161.49%	-416.02%	61.52%	-403.43%	-887.20%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	95.01%	-31.94%	-5.64%	39.84%	120.53%	363.51%	-48.15%	355.26%	781.67%	0.00%	0.00%
Return on Equity (ROE)	-94.33%	11.61%	0.94%	-25.38%	-49.92%	-60.47%	12.83%	-55.23%	-115.74%	-74.28%	-153.93%
Cash Return on Invested Capital (CROIC)	-95.47%	-115.19%	-98.65%	-190.37%	-198.48%	-451.16%	-237.96%	-269.19%	-573.89%	-4,206.04%	-3,214.99%
Operating Return on Assets (OROA)	-44.13%	8.25%	3.52%	-11.88%	-27.61%	-38.12%	9.72%	-32.64%	-79.29%	8.69%	-24.25%
Return on Assets (ROA)	-53.36%	3.64%	-0.63%	-17.01%	-32.78%	-42.78%	7.27%	-37.06%	-85.73%	7.43%	-26.22%
Return on Common Equity (ROCE)	-94.33%	11.61%	0.94%	-25.38%	-49.92%	-60.47%	12.83%	-55.23%	-115.74%	-74.28%	-153.93%
Return on Equity Simple (ROE_SIMPLE)	-36.91%	0.00%	-45.85%	-44.32%	-43.62%	0.00%	-13.90%	-45.54%	-52.55%	0.00%	-170.71%
Net Operating Profit after Tax (NOPAT)	-25	8.06	1.56	-9.54	-17	-20	7.18	-12	-18	12	-15
NOPAT Margin	-34.33%	6.94%	1.59%	-13.03%	-37.53%	-57.01%	12.73%	-52.11%	-160.48%	27.49%	-307.18%
Net Nonoperating Expense Percent (NNEP)	-18.98%	-2.93%	-2.08%	-7.42%	-8.96%	-7.95%	-0.55%	-7.07%	-10.21%	-1.59%	-9.82%
Return On Investment Capital (ROIC_SIMPLE)	-8.57%	2.49%	-	-	-	-9.04%	-	-	-	9.71%	-
Cost of Revenue to Revenue	16.60%	15.73%	16.01%	12.89%	15.49%	14.77%	13.64%	15.62%	13.52%	7.16%	14.68%
SG&A Expenses to Revenue	112.29%	65.51%	66.13%	88.30%	115.15%	138.95%	57.92%	121.73%	235.76%	44.66%	374.39%
R&D to Revenue	20.16%	11.77%	15.58%	17.43%	22.99%	27.72%	15.32%	37.08%	79.98%	20.69%	149.76%
Operating Expenses to Revenue	132.44%	77.28%	81.72%	105.73%	138.13%	166.67%	73.24%	158.81%	315.74%	65.36%	524.15%
Earnings before Interest and Taxes (EBIT)	-34	11	4.52	-11	-22	-26	8.86	-15	-25	13	-21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-31	13	7.07	-9.26	-20	-24	8.33	-12	-24	14	-20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.03	6.93	10.25	11.80	11.23	8.63	4.65	5.90	7.89	5.43	2.75
Price to Tangible Book Value (P/TBV)	8.03	6.93	10.25	11.80	11.23	8.63	4.65	5.90	7.89	5.43	2.75
Price to Revenue (P/Rev)	3.24	3.60	6.44	8.26	10.65	11.56	6.62	8.77	15.69	10.24	20.43
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	13.34	14.88	22.34	26.89	33.06	40.35	14.09	27.68	40.39	386.44	43.16
Enterprise Value to Revenue (EV/Rev)	3.06	3.30	6.08	7.85	10.00	10.48	5.59	7.56	14.04	8.38	13.31
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.04	0.87	0.64	0.68	0.66	0.30	0.14	0.22	0.21	0.27	0.40
Long-Term Debt to Equity	1.04	0.87	0.64	0.68	0.66	0.30	0.14	0.00	0.00	0.00	0.00
Financial Leverage	-0.56	-0.69	-0.65	-0.69	-0.75	-0.87	-0.78	-0.88	-0.88	-1.00	-1.04
Leverage Ratio	2.54	2.16	1.88	2.05	2.02	1.84	1.68	1.95	1.83	1.88	2.13
Compound Leverage Factor	3.00	0.96	-0.32	2.93	2.39	2.04	1.30	2.21	1.97	1.61	2.30
Debt to Total Capital	50.95%	46.54%	38.88%	40.55%	39.82%	23.00%	12.47%	18.01%	17.65%	21.36%	28.42%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	18.01%	17.65%	21.36%	28.42%
Long-Term Debt to Total Capital	50.95%	46.54%	38.88%	40.55%	39.82%	23.00%	12.47%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	49.05%	53.46%	61.12%	59.45%	60.18%	77.00%	87.53%	81.99%	82.35%	78.64%	71.58%
Debt to EBITDA	-7.40	-16.20	-2.17	-2.22	-2.10	-0.97	-2.03	-0.65	-0.48	-0.45	-0.25
Net Debt to EBITDA	3.06	10.66	1.93	1.89	2.16	2.63	10.28	2.41	1.85	1.65	0.60
Long-Term Debt to EBITDA	-7.40	-16.20	-2.17	-2.22	-2.10	-0.97	-2.03	0.00	0.00	0.00	0.00
Debt to NOPAT	-5.46	-7.71	-2.25	-2.43	-2.30	-1.12	-1.68	-0.74	-0.62	-0.60	-0.34
Net Debt to NOPAT	2.26	5.07	2.00	2.08	2.37	3.04	8.51	2.74	2.38	2.18	0.82
Long-Term Debt to NOPAT	-5.46	-7.71	-2.25	-2.43	-2.30	-1.12	-1.68	0.00	0.00	0.00	0.00
Altman Z-Score	0.79	1.51	2.68	2.87	2.70	3.55	2.86	0.22	1.76	-1.20	-6.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.12	4.58	4.03	4.21	4.53	4.88	5.54	2.63	2.65	2.34	2.31
Quick Ratio	3.43	3.95	3.46	3.57	4.06	4.09	4.79	2.22	2.26	2.01	1.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-60	-34	-14	-48	-43	-51	-43	-36	-40	9.20	-27
Operating Cash Flow to CapEx	-11,832.92%	1,654.30%	365.69%	-14,807.63%	-23,814.67%	-20,274.42%	-11,065.46%	-15,846.24%	-319,964.29%	25,970.91%	0.00%
Free Cash Flow to Firm to Interest Expense	-9.63	-5.75	-2.60	-9.83	-10.72	-18.11	-21.37	-17.56	-19.80	5.02	-15.63
Operating Cash Flow to Interest Expense	-6.14	1.68	0.09	-3.96	-8.80	-3.11	-10.58	-7.21	-22.43	7.79	-14.81
Operating Cash Flow Less CapEx to Interest Expense	-6.19	1.57	0.07	-3.98	-8.84	-3.12	-10.68	-7.26	-22.44	7.76	-14.50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.96	0.91	0.77	0.76	0.57	0.51	0.62	0.48	0.36	0.31	0.06
Accounts Receivable Turnover	9.69	8.37	5.22	9.06	7.90	8.36	5.54	11.25	7.64	12.67	3.28
Inventory Turnover	3.32	3.01	3.76	2.74	3.20	2.26	3.25	1.47	1.34	0.00	0.00
Fixed Asset Turnover	269.53	266.47	234.93	201.92	150.03	111.52	111.43	63.62	40.08	29.10	4.57
Accounts Payable Turnover	3.60	3.73	3.17	3.63	1.68	1.62	2.93	1.86	0.72	0.54	0.26
Days Sales Outstanding (DSO)	37.65	43.62	69.90	40.28	46.20	43.65	65.88	32.45	47.79	28.81	111.32
Days Inventory Outstanding (DIO)	109.99	121.37	97.20	132.98	114.22	161.32	112.33	248.50	272.32	0.00	0.00
Days Payable Outstanding (DPO)	101.51	97.96	115.06	100.64	216.87	225.59	124.68	196.17	509.35	670.95	1,409.55
Cash Conversion Cycle (CCC)	46.14	67.02	52.03	72.62	-56.45	-20.63	53.53	84.78	-189.24	-642.14	-1,298.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	83	74	69	61	48	32	53	23	22	1.13	2.78
Invested Capital Turnover	5.52	6.27	4.13	5.01	4.54	7.44	4.79	7.88	5.59	-154.09	-3.02
Increase / (Decrease) in Invested Capital	35	42	15	39	26	31	51	24	21	2.94	12
Enterprise Value (EV)	1,108	1,102	1,532	1,648	1,592	1,305	751	627	886	437	120
Market Capitalization	1,170	1,201	1,622	1,734	1,695	1,439	889	727	989	534	184
Book Value per Share	$0.61	$0.73	$0.67	$0.63	$0.65	$0.72	$0.88	$0.57	$0.61	$0.52	$0.43
Tangible Book Value per Share	$0.61	$0.73	$0.67	$0.63	$0.65	$0.72	$0.88	$0.57	$0.61	$0.52	$0.43
Total Capital	297	324	259	247	251	217	218	150	152	125	93
Total Debt	151	151	101	100	100	50	27	27	27	27	27
Total Long-Term Debt	151	151	101	100	100	50	27	0.00	0.00	0.00	0.00
Net Debt	-63	-99	-90	-86	-103	-134	-138	-101	-103	-97	-64
Capital Expenditures (CapEx)	0.33	0.59	0.14	0.13	0.15	0.04	0.19	0.09	0.01	0.06	-0.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	23	29	23	15	-1.53	11	33	-0.10	0.49	-9.20	3.84
Debt-free Net Working Capital (DFNWC)	237	279	214	201	201	196	198	127	131	115	94
Net Working Capital (NWC)	237	279	214	201	201	196	198	100	104	88	68
Net Nonoperating Expense (NNE)	16	3.42	2.37	6.91	9.24	9.21	0.55	5.48	8.53	1.45	7.58
Net Nonoperating Obligations (NNO)	-63	-99	-90	-86	-103	-134	-138	-101	-103	-97	-64
Total Depreciation and Amortization (D&A)	2.74	2.50	2.55	2.23	2.19	1.49	-0.53	3.51	1.04	1.03	1.18
Debt-free, Cash-free Net Working Capital to Revenue	6.33%	8.55%	9.21%	6.96%	-0.96%	9.18%	24.28%	-0.12%	0.78%	-17.63%	42.65%
Debt-free Net Working Capital to Revenue	65.48%	83.52%	84.81%	95.52%	126.36%	157.26%	147.23%	153.84%	207.53%	219.93%	1,048.56%
Net Working Capital to Revenue	65.48%	83.52%	84.81%	95.52%	126.36%	157.26%	147.23%	121.19%	164.90%	168.72%	753.96%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.17)	$0.01	$0.00	($0.07)	($0.11)	($0.12)	$0.03	($0.08)	($0.13)	$0.12	($0.14)
Adjusted Weighted Average Basic Shares Outstanding	238.62M	235.23M	235.91M	234.57M	233.07M	219.33M	222.78M	214.95M	207.02M	158.69M	165.10M
Adjusted Diluted Earnings per Share	($0.17)	$0.01	$0.00	($0.07)	($0.11)	($0.12)	$0.03	($0.08)	($0.13)	$0.12	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	238.62M	235.23M	235.91M	234.57M	233.07M	219.33M	227.89M	214.95M	207.02M	158.69M	165.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	239.26M	238.36M	236.85M	235.43M	233.98M	232.69M	232.14M	217.86M	214.46M	206.49M	187.46M
Normalized Net Operating Profit after Tax (NOPAT)	-25	8.06	1.56	-9.54	-17	-20	7.18	-12	-18	8.50	-15
Normalized NOPAT Margin	-34.33%	6.94%	1.59%	-13.03%	-37.53%	-57.01%	12.73%	-52.11%	-160.48%	19.24%	-307.18%
Pre Tax Income Margin	-54.36%	4.03%	-0.78%	-22.38%	-57.36%	-82.85%	12.11%	-76.66%	-235.37%	24.21%	-459.15%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.43	1.80	0.86	-2.34	-5.50	-9.15	4.37	-7.38	-12.40	6.83	-12.33
NOPAT to Interest Expense	-4.06	1.38	0.30	-1.95	-4.26	-6.98	3.54	-5.70	-9.14	6.62	-8.92
EBIT Less CapEx to Interest Expense	-5.49	1.70	0.83	-2.37	-5.54	-9.16	4.27	-7.43	-12.41	6.80	-12.02
NOPAT Less CapEx to Interest Expense	-4.12	1.28	0.27	-1.97	-4.29	-7.00	3.44	-5.74	-9.14	6.59	-8.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Ardelyx's Financials

When does Ardelyx's fiscal year end?

According to the most recent income statement we have on file, Ardelyx's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ardelyx's net income changed over the last 10 years?

Ardelyx's net income appears to be on an upward trend, with a most recent value of -$39.14 million in 2024, rising from -$3.21 million in 2014. The previous period was -$66.07 million in 2023. See Ardelyx's forecast for analyst expectations on what’s next for the company.

What is Ardelyx's operating income?

Ardelyx's total operating income in 2024 was -$27.95 million, based on the following breakdown:

Total Gross Profit: $283.06 million
Total Operating Expenses: $311.01 million

How has Ardelyx revenue changed over the last 10 years?

Over the last 10 years, Ardelyx's total revenue changed from $31.62 million in 2014 to $333.62 million in 2024, a change of 955.0%.

How much debt does Ardelyx have?

Ardelyx's total liabilities were at $262.47 million at the end of 2024, a 100.7% increase from 2023, and a 397.7% increase since 2014.

How much cash does Ardelyx have?

In the past 10 years, Ardelyx's cash and equivalents has ranged from $21.47 million in 2023 to $181.13 million in 2019, and is currently $64.93 million as of their latest financial filing in 2024.

How has Ardelyx's book value per share changed over the last 10 years?

Over the last 10 years, Ardelyx's book value per share changed from 3.27 in 2014 to 0.73 in 2024, a change of -77.6%.

Related Companies

This page (NASDAQ:ARDX) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ardelyx (ARDX) Financials

Frequently Asked Questions About Ardelyx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ardelyx (ARDX) Financials

Annual Income Statements for Ardelyx

Quarterly Income Statements for Ardelyx

Annual Cash Flow Statements for Ardelyx

Quarterly Cash Flow Statements for Ardelyx

Annual Balance Sheets for Ardelyx

Quarterly Balance Sheets for Ardelyx

Annual Metrics And Ratios for Ardelyx

Quarterly Metrics And Ratios for Ardelyx

Frequently Asked Questions About Ardelyx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools